Premarket Breakfast for Monday, August 5th

Gm traders.  

Global stocks are crashing today after (1) China devalued its currency in its fight against the trade war, making its lowest levels since 2008 (2) China will suspend agricultural imports from US.
Gap Percent Ticker Company Name Industry Company Size Market Cap Description Tags Insights
67.7% ALLK Allakos Inc. biotech (stomach inflammation) small cap 1.4 Billion
Co released phase 2 results on its drug for eosinophilic gastritis (stomach inflammation) which met all primary and secondary endpoints.  show more
drug results
13.4% ITCI Intra-Cellular Therapies, Inc. biotech (psychiatric drugs) micro cap 456 Million
Co announces its PDUFA will be rescheduled to Dec 27th for its drug lumaterperone for the treatment of schizophrenia.  show more
5.4% SNDL Sundial Growers cannabis --
No fresh news, but company is recent IPO.
recent IPO
3.9% ABMD Abiomed, Inc. medical device (heart pump) mid cap 9.28 Billion
Analyst bullish on stock after the final impatient prospective payment system rates were issued by the Center for Medicare & Medicaid Services.  show more
3.3% PRVB Provention Bio, Inc. biotech (diabetes) micro cap 376 Million
Co filed $200mm shelf and also announces breakthrough therapy designation for its drug Teplizumab for prevention or delay of Type 1 diabetes.
fast track
offering
0.0% AMRX Amneal Pharmaceuticals, Inc. generic drugs small cap 1.05 Billion
CEO and President leaving Co, also earnings.  show more
guides down
earnings
-2.2% HSBC HSBC Holdings plc banks large cap 164 Billion
CEO is leaving after 18 months on the job. show more
management leaving
-7.4% ON ON Semiconductor Corporation Technology - Semiconductor - Broad Line - USA mid cap 8.45 Billion
Earnings, and downside guidance.  show more
guides down
earnings
-11.3% CARS Cars.com Inc. automotive classified website small cap 1.26 Billion
Co announces end to strategic review with no bids.  show more
no buyers
-53.8% GLYC GlycoMimetics, Inc. biotech (sickle cell disease) micro cap 399 Million
Co's drug Rivipansel for sickle cell disease phase 3 study failed to meet primary and secondary endpoints. show more
drug results
Make sure you check out the Daily Episode

Behind The Bid has everything you need for your Premarket.
Visit daily for actionable, individual stock news at a glance.
Try our daily Premarket watchlist and daily Premarket YouTube show on at 8:20am ET.

Comments

Nana Yaw posted -
Really curious to find out where $prvb will end up today
[deleted] posted -

deleted

Nana Yaw posted -
Most of what l was looking at today wasn't quite decisive, obviously with tensions currently high in the trade wars. Hoping 
for a  much smooth session tomorrow

© 2019 Behind The Bid, LLC